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Abstract
Background: No midwifery-led units existed in Ireland before 2004. The aim of this study was to compare
midwife-led (MLU) versus consultant-led (CLU) care for healthy, pregnant women without risk factors for labour
and delivery.
Methods: An unblinded, pragmatic randomised trial was designed, funded by the Health Service Executive (Dublin
North-East). Following ethical approval, all women booking prior to 24 weeks of pregnancy at two maternity
hospitals with 1,300-3,200 births annually in Ireland were assessed for trial eligibility.1,653 consenting women were
centrally randomised on a 2:1 ratio to MLU or CLU care, (1101:552). ‘Intention-to-treat’ analysis was used to
compare 9 key neonatal and maternal outcomes.
Results: No statistically significant difference was found between MLU and CLU in the seven key outcomes:
caesarean birth (163 [14.8%] vs 84 [15.2%]; relative risk (RR) 0.97 [95% CI 0.76 to 1.24]), induction (248 [22.5%] vs 138
[25.0%]; RR 0.90 [0.75 to 1.08]), episiotomy (126 [11.4%] vs 68 [12.3%]; RR 0.93 [0.70 to 1.23]), instrumental birth (139
[12.6%] vs 79 [14.3%]; RR 0.88 [0.68 to 1.14]), Apgar scores < 8 (10 [0.9%] vs 9 [1.6%]; RR 0.56 [0.23 to 1.36]),
postpartum haemorrhage (144 [13.1%] vs 75 [13.6%]; RR 0.96 [0.74 to 1.25]); breastfeeding initiation (616 [55.9%] vs
317 [57.4%]; RR 0.97 [0.89 to 1.06]). MLU women were significantly less likely to have continuous electronic fetal
monitoring (397 [36.1%] vs 313 [56.7%]; RR 0.64 [0.57 to 0.71]), or augmentation of labour (436 [39.6%] vs 314
[56.9%]; RR 0.50 [0.40 to 0.61]).
Conclusions: Midwife-led care, as practised in this study, is as safe as consultant-led care and is associated with
less intervention during labour and delivery.
Trial registration number: ISRCTN: ISRCTN14973283
Background
Maternity care in Ireland is predominantly hospital-based
and consultant-led. In the early 21st century, it is pro-
vided free of charge to all women attending the ‘public’,
hospital-based, service. Approximately 50% of women
have private insurance that covers, or partially covers, the
costs for them to attend for care on a ‘semi-private’ or
‘private’ basis. The three types of care differ as follows:
￿ Public: cared for antenatally by a team of doctors
led by a consultant, cared for in labour and at birth
by a team of qualified and student midwives, under
the supervision of obstetricians, cared for in the
postnatal period in hospital in a public ward, usually
with 5 or more beds, for 2-3 days.
￿ Semi-private: cared for antenatally by a non-con-
sultant qualified obstetrician, cared for in labour and
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under the supervision of the obstetrician on call,
cared for in the postnatal period in hospital in a
semi-private, usually 2-4-bedded ward, for 2-3 days.
Not available in all hospitals.
￿ Private: cared for antenatally by a chosen consul-
tant obstetrician, cared for in labour and at birth by
a team of qualified and student midwives, under the
supervision of the obstetrician or their designated
replacement, who will often be present for the birth,
cared for in the postnatal period in hospital in a pri-
vate room for 2-5 days.
Some hospitals provide ‘out-reach’ antenatal and post-
natal care clinics, but there are no national community
midwifery services available in the public health system,
providing either antenatal or postnatal care. The Public
Health Nursing service provides a minimum of one
home visit, usually within 2 days of discharge from hos-
pital, and further visits if necessary. Women attend their
general practitioner (GP) at six weeks for a check-up of
themselves and their baby. A small number of self-
employed community midwives care for women having
a home birth, (n = 148 births, 0.2% of the total 76,021
births in 2009) [1].
This hospital-based, consultant-led model of maternity
care in Ireland has been described as ‘highly medica-
lised’ [2] typified by the use of various forms of ‘active
management of labour’ (AML) in most of the 20 mater-
nity units in Ireland. AML includes involvement of a
consultant obstetrician, one-to-one midwifery care and
use of routine artificial rupture of membranes (ARM)
and intravenous oxytocin if a woman’sc e r v i xi sn o t
dilating by one centimetre per hour [3]. It has been sug-
gested that the main beneficial effect of AML may arise
from continuous support of a midwife rather than rou-
tine use of amniotomy and oxytocin [3]. Certainly, early
routine ARM, one facet of AML, has been criticised as
“not scientifically justified” [4] and a Cochrane Review
found “no shortening of the length of first stage of
labour and a possible increase in caesarean section”,
concluding “routine amniotomy is not recommended for
normally progressing labours or in labours which have
become prolonged” [5]. Another Cochrane Review
found that AML was associated with a small decrease in
caesarean section (CS), but that it was “highly prescrip-
tive and interventional” [6] and the authors advised
further research to determine the acceptability of AML
to women [6].
Other models, including midwife-led care, tend to be
less prescriptive and are founded on the principle of
childbirth being a normal, physiological yet life-changing
event. ‘Midwife-led care’ is defined as care where mid-
wives are, “in partnership with the woman, the lead
professional with responsibility for assessment of her
needs, planning her care, referral to other professionals
as appropriate, and for ensuring provision of maternity
services” [7]. Midwife-led units (MLUs) are seen as an
important and necessary development in care [8] and
offer the majority of women a woman-centred, [9,10]
cost-effective, [10] safe [11] and satisfying [9,10,12,13]
alternative to consultant-led care. The most recent pub-
lished version of the Cochrane Review comparing mid-
wife-led with other forms of care in pregnancy and
childbirth involved 11 trials including 12,276 women.
Six studies included women at low risk of complications
and five recruited women of high, or mixed, levels of
risk. Women who received midwife-led care were less
likely to have fetal/neonatal loss before 24 weeks, epi-
siotomy, regional analgesia/anaesthesia, instrumental
birth, or antenatal hospitalisation; and were more likely
to have no intrapartum analgesia/anaesthesia, sponta-
neous vaginal birth, to feel in control, to be attended at
birth by a known midwife and to initiate breastfeeding.
Infants of mothers randomised to midwife-led care had
a shorter mean length of neonatal hospital stay. No dif-
ference was found in antepartum haemorrhage, mean
number of antenatal visits, overall fetal loss and neonatal
death, fetal loss or neonatal death ≥ 24 weeks, amniot-
omy, labour augmentation, mean length of labour,
induction of labour, use of opiate analgesia, caesarean
section, perineal laceration requiring suturing, intact
perineum, postpartum haemorrhage, duration of postna-
tal hospital stay, low birth weight infant, preterm birth,
Apgar scores ≤ 7 at 5 minutes, admission of infant to
special care or neonatal intensive care, neonatal convul-
sions, or maternal postpartum depressions. The review
concludes “most women should be offered midwife-led
models of care and women should be encouraged to ask
for this option” [7]. In Ireland, there were no MLUs
before 2004, and few examples of midwife-led care. In
2001, the Kinder Report on women’s health services in
the North-Eastern region emphasised the need for evi-
dence-based care and recommended that MLUs be
established in Cavan and Drogheda [14]. Amid uncer-
tainty as to how far the findings of the Cochrane Review
on midwife-led care could be applied to an Irish popula-
tion, the former North-Eastern Health Board (NEHB)
(now the Health Service Executive, Dublin North-East
(HSE-DNE)) planned the introduction of ‘alongside’
midwife-led units within a randomised trial (the “MidU”
study). The aim was to compare the effects of midwife-
led care (in an MLU) with consultant-led care for
healthy women without risk factors for labour and deliv-
ery, on rate of interventions, maternal satisfaction, and
neonatal and maternal outcomes. In addition, the costs
of both types of care were to be measured and com-
pared. Rate of interventions, neonatal and maternal
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maternal satisfaction will be presented in future papers.
Methods
Study setting and participants
Two MLUs were constructed in Our Lady of Lourdes
Hospital (OLOL) in Drogheda (3,200 births per year)
and Cavan General Hospital (CGH), Cavan (1,300 births
per year), both located in large towns (28,000 and 4,000
inhabitants respectively) serving a semi-urban and rural
population, of mixed race, with white Irish in the major-
ity. Both units were housed within their parent hospital
in re-furbished existing accommodation, close to the
main labour ward, and aimed to provide an integrated
service using evidence-based guidelines and procedural
policies. Twelve staff midwives were employed in OLOL
MLU and seven in CGH.
This two group, two-centre, pragmatic randomised trial
was conducted between July 2004 and June 2007, with a
pilot study for the first seven months, which refined the
eligibility criteria and practice guidelines. No changes
were made to methods after trial commencement.
Recruitment to the main study took place from February
2005 to November 2006, with the last birth in June 2007
when the full sample size had been reached. The null
hypothesis stated that “t h e r ew i l lb en od i f f e r e n c ef o u n d
between midwife-led care and consultant-led care for
healthy women without risk factors for labour and deliv-
ery as measured by rate of interventions, maternal satis-
faction and neonatal and maternal morbidity outcomes”.
Information on the MLU service and study invitations
were sent by post, or via their GP, to women availing of
public care in the HSE-DNE. At the booking clinic,
women who had not completed 24 weeks of pregnancy
were assessed for trial eligibility by midwives, using
multi-disciplinary agreed guidelines (Table 1), and had
all questions answered. Those who agreed to participate
gave written consent.
The Faculty of Health Sciences Research Ethics Com-
mittee of Trinity College Dublin and the former NEHB
approved the study. An independent Data and Safety
Monitoring Board (DSMB) was established and con-
ducted an interim analysis on data on the first 495
women in the main study (33%), with a stopping guide-
line alpha of 0.001 [15]. The DSMB found insufficient
evidence of benefit or harm in either group and recom-
mended the study should continue. The second interim
analysis did not take place as the full sample size had
already been recruited by the time manual collection of
all data on the first 66% of the planned sample size had
been completed.
Randomisation and masking
Women were randomised to a MLU or consultant-led
unit (CLU) in a two to one ratio (to make cost-effective
use of the refurbished MLUs and allocated staff), using
an independent telephone randomisation service. Ran-
dom sequences of block sizes of two, three, four or five
were used, stratified by study centre using a separate
block randomisation list for each of the two centres,
and by random permutations of group allocation within
each block. Block sizes were concealed until completion
of the trial. Random integers were obtained using a ran-
dom number generator available in StatsDirect [16]. The
enrolling midwife logged demographics, eligibility, con-
sent and contact details, provided this to the randomisa-
tion service and was then informed of the allocation
(MLU or CLU) and the unique study number.
As there was no access to MLU care except through
the study, carers were aware that all women in the
MLU were included in MidU. Therefore, identification
of women randomised to the CLU group was not
masked, as blinding participants allocated to control
groups when it is impossible to blind those in experi-
mental groups has been criticised [17]. Ensuring that all
women, and their carers, were aware of their trial status
should minimise the impact of this on differences in
outcomes between the groups.
Procedures
Women randomised to CLU received standard care:
antenatal care provided by obstetricians and, if desired,
Table 1 Trial eligibility - maternal exclusion criteria
￿ ≥ 40 years of age and ≤16 years age at
delivery
￿ Grand multiparity (> 5)
￿ Height: < 152 cms (5 feet)
￿ BMI < 18 or > 29
￿ Medical History: respiratory, renal, infective,
immune, neurological, cardiovascular,
gastrointestinal, endocrine, haematological,
mental ill-health, muscoskeletal
￿ Social
Current history of drug misuse
Smoking ≥ 20 cigarettes per day
￿ Latex allergy
￿ Previous obstetric history
History of preterm birth at < 34 weeks gestation,
recurrent miscarriage, moderate to severe pre-
eclampsia,intra-uterine growth restriction,
previous stillbirth, CS, eclampsia, uterine rupture,
placental abruption, PUPP, obstetric cholestasis,
3rd or 4th degree tear, PPH (> 500 mls or
symptomatic), manual removal of placenta,
shoulder dystocia, midtrimester miscarriage,
neonatal death, infant with hypoxic ischaemic
encephalopathy
￿ Previous gynaecological history
Uterine surgery, myomectomy, hysterotomy,
cone biopsy (unless subsequent term vaginal
delivery), two previous Letz procedures, uterine
fibroids, cervical cerclage, infertitlity, uterine
anomaly, perineal reconstruction (more than 24
hours post birth)
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team with assistance from midwives, who did not
usually perform assessment; intrapartum care provided
by midwives unless complications developed, with con-
sultant overview; and postpartum care (2-3 days in hos-
pital) provided by midwives, overseen by consultants.
Women were discharged into the care of Public Health
Nurses.
Women randomised to MLU received midwife-led
care where care was provided by the same small group
of midwives throughout pregnancy, birth and into the
postnatal period. Antenatal care (including assessment)
w a sp r o v i d e db ym i d w i v e si nt h eu n i t ,o ri na no u t -
reach clinic and, if desired, by the woman’sG P .W h e r e
complications arose, women were transferred to CLU
b a s e do na g r e e dc r i t e r i a( T a ble 2). Following obstetric
assessment women transferred back to MLU or
remained in CLU as appropriate, where they received
the usual care described above. Intrapartum care was
provided by midwives in the MLU with transfer to
CLU if necessary, based on agreed criteria (Table 3).
Postnatal care was by midwives in the MLU for up to
two days, with transfer of women or neonates to CLU
if necessary (and back, as appropriate), based on
agreed criteria (Table 4). On discharge, MLU midwives
visited at home, and/or provided telephone support, up
to the seventh postpartum day, when care was trans-
ferred to the Public Health Nursing service. Care in
the MLUs was provided by the full team of midwives
( 1 2i nO L O La n d7i nC G H ) ,s ow o m e nd i dn o tn e c e s -
sarily have the degree of continuity of care that might
be expected from case-load models of midwife-led
care.
Data were collected manually from women’sa n dn e o -
nates’ charts by research assistants and double-entered
into a computerised database, checked and cleaned. Ver-
ified data were transferred into SPSS (version 16.0) for
analysis.
Statistical analysis
MidU contained several primary outcomes, reflecting
the diversity of opinion about which outcomes are most
important in maternity care. The sample size required
was 1,539, taking account of the two to one randomisa-
tion ratio and based on two-tailed tests. This assumed a
criterion for significance (alpha) of 0.05, and sufficient
power (at ≥ 0.80) to detect differences of at least 6%
between consultant-led carea n dm i d w i f e - l e dc a r ei n
MLUs in rates of induction of labour (23% to 17%), epi-
siotomy (31% to 24%) and augmentation of labour
(24.4% to 17.9%). Effect sizes for primary outcome mea-
sures were informed by the literature and agreed by
study site clinicians. This sample size would also, with
the same or greater levels of significance and power,
detect differences in proportions between CLU and
MLU in Apgar score at five minutes of 8-10: (97.2% to
93.2%); initiation of breastfeeding: (40% to 50%); CS:
(11.2% to 6.2%); continuous electronic fetal monitoring
(EFM): (23% to 16%); instrumental birth: (10.4% to
5.4%); postpartum haemorrhage (> 500 mls): (8% to 4%);
and mean umbilical cord pH: mean difference of 0.02
with a common within-group standard deviation of
0.096. Secondary outcomes were also identified and
listed in the study protocol.
Data analysis was by ‘intention-to-treat’. Study results
are reported as a summary of the outcome in each
Table 2 Transfer criteria during pregnancy
Maternal Maternal Maternal Fetal
￿ Rhesus disease ￿ Prolonged pregnancy i.e. > 40
+10
￿ Gestational diabetes ￿ Clinically suspected small for
gestational age baby
￿ Atypical antibodies ￿ Pre-term spontaneous rupture
of the membranes
￿ Pre-labour rupture of membranes at term for >
48 hrs
￿ Known fetal anomaly
￿ Antepartum haemorrhage ￿ Gestational Hypertension (≥
140/90 mmHg)
￿ Induction of labour ￿ Oligo-hydramnious
￿ Multiple pregnancy ￿ Eclampsia ￿ Symptomatic vaginal discharge. ￿ Poly-hydramnious
￿ Maternal request for
prenatal screening
￿ Pre-eclampsia ￿ Unbooked pregnancy ￿ Reduced fetal movements
￿ Plancental abruption ￿ Proteinuria ≥ 1+ on repeat
specimen at same visit.
￿ Group B Strep
￿ Unstable lie ￿ Suspected thromboembolism ￿ More than two admissions in ≥ 48 hours at term
and not in established labour
￿ Malpresentation after 37
completed weeks
￿ Any itchy rash
￿ Placenta praevia ￿ Hb < 10 g/dL
￿ Preterm labour before 37
completed weeks
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randomised), or the mean and standard deviation of
measurements. Summary statistics using risk ratios
(relative risks (RR)) for dichotomous outcomes, and
mean difference for continuous outcomes are reported,
with 95% confidence intervals (CI) [18].
The protocol for the MidU study was registered with
the International Standard Randomised Controlled Trial
Number Register (ISRCTN14973283, http://www.con-
trolled-trials.com/ISRCTN14973283) and no important
changes were made to the methods after the trial
started. Results are reported in accordance with the lat-
est CONSORT statement [19-21].
Results
Of the 9,804 women informed about the study, 4,190
(43%) were eligible to participate. Fifty-four percent (n =
2260) consented to join, 607 in the pilot and 1,653 in
the main study. In the main study, reported here, 1,101
were randomised to MLU and 552 to CLU. Of the 1,653
women, 1,206 attended OLOL (73%) and 447 attended
CGH (27%). Baseline characteristics were similar (Table
5). Data for five MLU women (0.5%) and three CLU
women (0.5%) were incomplete because they moved
home during pregnancy and could not be traced. Nine-
teen ineligible women were randomised to MLU (1.7%)
and therefore transferred to CLU, but their data were
analysed in the MLU group, in accordance with the
intention-to-treat principle. Two ineligible women were
randomised to CLU (0.4%). Twenty-four women (2.2%)
randomised to MLU changed their minds following ran-
domisation and requested CLU care. Five women rando-
mised to MLU (0.5%) requested private consultant care.
One woman randomised to MLU (0.1%) and two
women randomised to CLU (0.4%) opted for home-birth
(Figure 1). In all, 492 (44.7%) women transferred perma-
nently to CLU in the antenatal period, 144 (13.1%) dur-
ing labour and 5 (0.5%) in the postnatal period, based
on a priori criteria (Tables 2, 3 and 4). The most com-
mon reason for transfer antenatally was for induction of
labour (n = 202, 41%), with fetal assessment (n = 38,
8%) as the next most common reason. In labour, the
most common reasons for transfer were slow progress
(n = 61, 41%) and meconium stained liquor (n = 26,
18%).
In accordance with the intention-to-treat principle,
d a t aa r ea n a l y s e di nt h eg r o u pt ow h i c ht h ew o m e n
were allocated by randomisation. Seven primary
Table 3 Intrapartum transfer criteria
Maternal Maternal Fetal Fetal
￿ Placental abruption ￿ Shoulder
dystocia
￿ Abnormal fetal heart rate on auscultation - if
prolonged deceleration ≥ 2 mins < 110 bpm is
diagnosed, the woman was transferred to the CLU
￿ Meconium
stained liquor
￿ Pyrexia > 38°C on two occasions at least 1 hour
apart
￿ Request for
epidural
￿ Malpresentation
(with exception of
mento-anterior)
￿ Lack of progress in the first stage of labour (absent
or slower cervical dilatation than 0.5 cm/hr for
primigravidae and 1 cm/hr for multigravidae
￿ Unbooked
and presenting
in early labour
￿ Intrapartum
haemorrhage
￿ Delay in the second stage of labour (active pushing
for more than 90 mins primigravidae or 40 mins for
multigravidae)
￿ Retained
placenta (> 1
hr)
￿ Cord
presentation/
prolapsed
￿ PPH (> 1000
mls or if
symptomatic)
￿ Fetal demise
￿ 3
rd/4
th degree
perineal tears
￿ Absence of liquor
Table 4 Postnatal transfer criteria
Maternal Maternal Maternal
￿ Postpartum
haemorrhage (> 500
mls)
￿ Signs of deep vein thromboembolism: leg pain or
discomfort, (especially in the left leg), swelling, tenderness,
increased temperature and oedema, and lower abdominal
pain
￿ Signs of pulmonary thromboembolism: dyspnoea,
collapse, chest pain, haemoptysis, faintness, and signs and
symptoms associated with DVT
￿ Pyrexia > 38
C on two
occasions at least 1
hour apart
￿ Any other condition that causes concern
￿ Concerns for psycho-
logical wellbeing
Begley et al. BMC Pregnancy and Childbirth 2011, 11:85
http://www.biomedcentral.com/1471-2393/11/85
Page 5 of 10outcomes showed no statistically significant difference
between MLU and CLU: caesarean birth (163 [14.8%] vs
84 [15.2%]; relative risk (RR) 0.97, 95% CI 0.76, 1.24),
induction of labour (248 [22.5%] vs 138 [25.0%]; RR
0.90, 95% CI 0.75, 1.08), episiotomy (126 [11.4%] vs 68
[12.3%]; RR 0.93, 95% CI 0.70, 1.23), instrumental birth
(139 [12.6%] vs 79 [14.3%]; RR 0.88, 95% CI 0.68, 1.14),
Apgar scores less than 8 (10 [0.9%] vs 9 [1.6%]; RR 0.56,
95% CI 0.23, 1.36), postpartum haemorrhage (PPH) (144
[13.1%] vs 75 [13.6%]; RR 0.96, 95% CI 0.74, 1.25) and
initiation of breastfeeding (616 [55.9%] vs 317 [57.4%];
RR 0.97, 95% CI 0.89, 1.06) (Table 6).
MLU women were significantly less likely to receive
continuous EFM (available only in CLU) (397 [36.1%] vs
313 [56.7%]; RR 0.64, 95% CI 0.57, 0.71), or have labour
augmented by amniotomy or with oxytocin (436 [39.6%]
vs 314 [56.9%]; RR 0.50, 95% CI 0.40, 0.61) (Table 6).
Cord blood pH measurement could not be undertaken
without cord-clamping, which was not part of the proto-
col of care in the MLUs (because cord-clamping would
have excluded expectant third stage management).
Of the secondary maternal outcomes, 6 showed no
statistically significant difference between MLU and
CLU: at least one antenatal admission (487 [44.2%] vs
229 [41.5%]; RR 1.07, 95% CI 0.95, 1.20); experienced
any pregnancy complication (248 [22.5%] vs 110 [19.9%];
RR 1.13, 95% CI 0.93, 1.38); fetal loss before 24 weeks
(17 [1.54%] vs 5 [0.91%]; RR 1.70, 95% CI 0.63, 4.60);
spontaneous vaginal birth (761 [69.1%] vs 372 [69%]; RR
1.03, 95% CI 0.96, 1.10); intact perineum (421 [38.2%] vs
225 [40.8%]; RR 0.96, 95% CI 0.85, 1.09); estimated
mean blood loss (323 mls (SD 317) vs 324 mls (SD 401);
MD 6.17, 95% CI-32.12, 44.46) (Table 7).
Women randomised to MLU had significantly fewer
mean ultrasound examinations (1.98 (SD 1.37) vs 2.49
(SD 1.75), mean difference (MD) -0.51, 95% CI -0.68,
-0.34), and antenatal cardiotocographs (2.38 (SD 3.6) vs
3.39 (SD 3.77), MD -1.01 95% CI -1.39, -0.63). Signifi-
cantly fewer MLU women chose to have epidurals (for
which they had to transfer to CLU) (202 [18.3%] vs 134
[24.3%]; RR 0.76, 95% CI 0.62, 0.92). Alternative methods
of pain relief included transcutaneous electrical nerve sti-
mulation (TENS) (64 [16%] vs 170 [12%]; RR 1.33, 95%
CI 1.02, 1.74 and hydrotherapy (birthing pool in MLU,
bath in CLU) (257 [23.3%] vs CLU 18 [3.3%]; RR 7.16,
95% CI 4.49, 11.42). Twenty-seven percent of MLU
women (n = 297) had only one or two caregivers in
labour, compared with 17% (n = 94) in CLU (RR 1.58,
95% CI 1.29, 1.95). MLU women had a longer mean
length of labour (4.6 hours (SD 3.27) vs 4.0.hours (SD
2.41); mean difference 0.53, 95% CI 0.25, 0.81) (Table 7).
MLU women more frequently used spontaneous pushing
(726 [65.9%] vs 308 [55.8%]; RR 1.18, 95% CI 1.08, 1.29),
upright positions for birthing (300 [27.2%] vs 55 [10.0%];
RR 2.73, 95% CI 2.09, 3.58), physiological management of
third stage of labour (137 [12.4%] vs 1 [0.2%]; RR 68.69,
95% CI 9.63, 489.80). More MLU women stayed only one
postnatal day or less (184 [16.7%] vs 57 [10.3%]; RR 1.62,
95% CI 1.22, 2.14) (Table 7).
Neonatal outcomes showed no statistically significant
difference between MLU and CLU in paediatric care
required (292 [26.5%] vs 150 [27.2%]; RR 0.98, 95% CI
0.82, 1.15); facial oxygen (130 [11.8%] vs 63 [11.4%]; RR
1.03, 95% CI 0.78, 1.37); bag-and-mask resuscitation (23
[2.1%] vs 12 [2.2%]; RR 0.96, 95% CI 0.48, 1.92); admis-
sion to special care baby unit (SCBU) (128 [11.6%] vs 60
[10.9%]; RR 1.07, 95% CI 0.80, 1.43) (Table 7). There
were two early neonatal deaths in MLU (0.18%), two
(0.36%) in CLU, and one (0.1%) fetal loss at > 24 weeks
in MLU. Perinatal mortality rates in MLU and CLU
were 2.76 and 3.66 per 1,000 live and still-births. There
were no maternal deaths. Other secondary and sub-
group analyses are in the full study report [22]. The
satisfaction survey and economic analysis will be
reported separately.
Table 5 Baseline characteristics
MLUs CLUs
Total 1101 552
Mean age years (SD) 29 (4.9) 28.7 (5.0)
Parity 0 (%) 565 (51.3) 276 (50)
Parity > 0 (%) 536 (48.7) 276 (50)
Single (%) 415 (37.7) 229 (41.5)
Married, not separated (%) 664 (60.3) 312 (56.5)
Mean weight Kgs (SD) 65.9 (8.9) 66.1 (8.93)
Mean height metres (SD) 1.66 (0.07) 1.66 (0.08)
SD = Standard deviation
Figure 1 Enrolment flowchart.
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The trial’s main limitation is the lack of blinding of par-
ticipants and carers as all women attending MLU were
known to be in the study intervention group. Those
allocated to CLU care were not masked either, as the
blinding of participants allocated to control groups in
such situations has been criticised [17]. Unavoidable
p o t e n t i a lb i a st h u se x i s t sf o rb o t hr a n d o m i s e dg r o u p s .
Assessors for certain outcomes, such as laboratory tests,
were blinded to study group. The outcome ‘blood loss’
was estimated, as per hospital protocols, and amounts
are thus imprecise in both groups.
T h ef o c u so ft h i ss t u d yw a so nt h er e l a t i v ee f f e c t so f
midwife-led care provided in the setting of an alongside
MLU. As such, this study combines elements of mid-
wife-led care including continuity of care in pregnancy
and birth with settings for birth i.e. the MLU. We
acknowledge that not all midwife-led models of care will
take place in an alongside MLU nor, indeed, in a home-
like environment [7]. Further, not all alternative settings
Table 6 Primary outcomes
Outcome MLU
(1101)
Event [%]
CLU
(552)
Event [%]
Summary statistic
95% CI
Caesarean section 163 [14.8%] 84 [15.2%] RR 0.97, 95% CI 0.76, 1.24
Induction of labour 248 [22.5%] 138 [25.0%] RR 0.90, 95% CI 0.75, 1.08
Episiotomy 126 [11.4%] 68 [12.3%] RR 0.93, 95% CI 0.70, 1.23
Instrumental birth 139 [12.6%] 79 [14.3%] RR 0.88, 95% CI 0.68, 1.14
Apgar scores less than 8 10 [0.9%] 9 [1.6%] RR 0.56, 95% CI 0.23, 1.36)
Postpartum haemorrhage (PPH) 144 [13.1%] 75 [13.6%] RR 0.96, 95% CI 0.74, 1.25
Initiation of breastfeeding 616 [55.9%] 317 [57.4%] RR 0.97, 95% CI 0.89, 1.06
Continuous EFM 397 [36.1%] 313 [56.7%] RR 0.64, 95% CI 0.57, 0.71
Labour augmentation 436 [39.6%] 314 [56.9%] RR 0.50, 95% CI 0.40, 0.61
Table 7 Secondary outcomes
Outcome MLU
(1101)
Event [%]
CLU
(552)
Event [%]
Summary statistic
95% CI
Ultrasound examinations 1.98 (1.4) 2.49 (1.8) MD -0.51, 95% CI -0.68, -0.34
Antenatal cardiotocographs 2.38 (3.6) 3.39 (3.8) MD -1.01 95% CI -1.39, -0.63)
Antenatal admission 487 [44.2%], 229 [41.5%] RR 1.07, 95% CI0.95, 1.20
Pregnancy complications 248 [22.5%] 110 [19.9%] RR 1.13, 95% CI 0.93, 1.38
Fetal loss prior to 24 weeks 17 [1.5%] 5 [0.9%] RR 1.70, 95% CI 0.63, 4.60
Epidurals 202 [18.3%] 134 [24.3%] RR 0.76, 95% CI 0.62, 0.92
Included transcutaneous electrical nerve stimulation (TENS) 64 [16.0%] 170 [12.0%] RR 1.33, 95% CI 1.02, 1.74
Hydrotherapy 257 [23.3%] 18 [3.3%] RR 7.16, 95% CI 4.49, 11.42
One or two caregivers 297 [27.0%] 94 [17.0%] RR 1.58, 95% CI 1.29, 1.95
Length of labour (hrs) 4.6 (3.3) 4.0 (2.4) MD 0.53, 95% CI 0.25, 0.81)
Spontaneous pushing 726 [65.9%] 308 [55.8%] RR 1.18, 95% CI 1.08, 1.29
Upright positions for birthing 300 [27.2%] 55 [10.0%] RR 2.73, 95% CI 2.09, 3.58
Physiological management of third stage of labour 137 [12.4%] 1 [0.2%] RR 68.69, 95% CI 9.63, 489.80
Spontaneous vaginal birth 761 [69.1%] 372 [69.0%] RR 1.03, 95% CI 0.96, 1.10
Intact perineum 421 [38.2%] 225 [40.8%] RR 0.96, 95% CI 0.85, 1.09
Estimated blood loss mls 323 (317) 324 (401) MD 6.17, 95% CI -32.12, 44.46
Postnatal stay of 1 day or less 184 [16.7%] 57 [10.3%] RR 1.62, 95% CI 1.22, 2.14
Paediatric care required 292 [26.5%] 150 [27.2%] RR 0.98, 95% CI 0.82, 1.15
Facial oxygen 130 [11.8%] 63 [11.4%] RR 1.03, 95% CI 0.78, 1.37
Bag-and-mask resuscitation 23 [2.1%] 12 [2.2%] RR 0.96, 95% CI 0.48, 1.92
Admission to special care baby unit 128 [11.6%] 60 [10.9%] RR 1.07, 95% CI 0.80, 1.43
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Page 7 of 10for birth will provide midwife-led care [23]. Differentiat-
ing the effects of midwife-led care from the setting of
that care is not possible within this study, a limitation
that is not unique to our study. The potential confound-
ing effect of practice settings such as MLU on the out-
comes of midwife-led care is complex as are the
interrelationships between philosophy and continuity of
care [7].
In this study, the percentage of women transferring
from MLU to CLU care in the antenatal period, in parti-
cular, is higher (at 45%) than quoted rates of 24% in
some UK centres [10]. The permanent transfer rates of
13% intrapartum and 0.5% postnatally are approximately
t h es a m ea st h e1 2 - 1 5 %a n du pt o8 %r e p o r t e di nt h e
UK [10]. Some of the reasons for permanent transfer
such as induction of labour and premature labour
should not automatically preclude women from being
transferred back to MLU care in the postnatal period, if
appropriate. Quality reviews and audits of reasons for
transfer would assist in reducing these high rates to
more normal levels.
The strength of this trial lies in its size, and in its ser-
endipitous conduct prior to the introduction of MLUs,
in Ireland, due to the enlightened vision of the (then)
North-Eastern Health Board in planning service innova-
tion formally within the framework of a clinical trial.
The MidU study is likely to have good external validity,
as the setting of the trial is similar to many birthing
units in the UK and other countries. Identifying eligible
women was done using clinical criteria of ‘low risk’ simi-
lar to, or sometimes more stringent than, those used in
many other centres, and 43% of women met those cri-
teria. As 50% of these women also agreed to join the
trial, there is a large enough proportion to warrant
introducing a new scheme. Furthermore, the MLU inter-
vention described in the trial protocol and implemented
in the trial itself for women allocated to the MLU arm
can be regarded as standard practice for MLU care in
the two study sites, since the relevant procedures were
established in the context of the MidU trial. Similarly,
the control intervention in MidU reflects standard prac-
tice for women receiving CLU care in these two sites.
We calculated the sample size for the MidU trial using
estimates for induction of labour, episiotomy and aug-
mentation of labour. We also calculated the effect sizes
that this would allow us to detect for other important
outcomes and included this information in the protocol
for the trial and within this report. We thus had several
“primary outcomes” because complex interventions such
as models of maternity care involve a variety of people
including pregnant women, practitioners, policy makers
and the public, all of whom are likely to be interested in
the results of a randomised trial. These people can have
different priorities when assessing the evidence from a
trial such as MidU, and it is unclear whose priorities
should be given prominence by choosing a single pri-
mary outcome. This diversity of opinion was confirmed
in many discussions before, during and after the trial
and, so, by explicitly selecting several primary outcomes,
we committed ourselves to making the findings for each
of these available in the report of the study, including
all adverse outcomes, as we have done here. In this way,
we leave it to readers to use their own priorities to
decide whether any single outcome, or combination of
outcomes, is the most important for their interpretation
of the findings of MidU.
The results reported here show that midwife-led care,
as practised in this study in an ‘alongside’ MLU, is as
safe as consultant-led care and is associated with less
intervention. Women cared for in the MLUs were sig-
nificantly less likely to receive continuous EFM, or have
their labour augmented, with no statistically significant
difference in adverse neonatal or maternal outcomes
such as low Apgar scores, resuscitation, admission to
SCBU, CS, instrumental birth or PPH. Other interven-
tion rates, such as episiotomy and induction of labour,
were similar in both groups.
The lower rate of EFM in the MLUs should be seen in
the context of knowledge that the predictive ability of
abnormal fetal heart rate patterns to identify fetal meta-
bolic acidosis and hypoxic-ischemic encephalopathy is
low [24]. The Cochrane Review of continuous cardioto-
cography (CTG) during labour found that, in 12 trials
with more than 37,000 women, continuous EFM was
associated with a significant increase in CS rates and
instrumental birth with no difference shown in cerebral
palsy or neonatal mortality. EFM was, however, asso-
ciated with a reduction in neonatal seizures [25]. Despite
the significantly lower use of EFM in women rando-
mised to MLU, there was no difference in the CS rates
between the groups. Although counter-intuitive, this
finding is consistent with the Cochrane Review on mid-
wife-led care [7]. The lower rate of instrumental vaginal
births is consistent with the Cochrane Reviews on both
continuous CTG [26] and midwife-led care [7].
Augmentation of labour, through ‘active management,’
was introduced in the 1970s in Ireland to prevent pro-
longed primigravid labours and save 60% on birth costs
[26]. A review comparing routine care with early
amniotomy and oxytocin for delay in first stage sponta-
neous labour found that early intervention was asso-
ciated with a modest reduction in CS rates but there
was insufficient evidence on maternal or neonatal out-
comes [27]. The higher augmentation rates for women
in CLU in this study are not associated with a reduction
in complications in the fetus or neonate, or with a
decrease in operative or instrumental birth rates, and
are therefore unnecessary in low-risk women.
Begley et al. BMC Pregnancy and Childbirth 2011, 11:85
http://www.biomedcentral.com/1471-2393/11/85
Page 8 of 10Recent editorial commentary in the Lancet recom-
mended that trialists should set their findings in the
context of an up-to-date systematic review, in order to
acknowledge the place of their results in the world lit-
erature [28]. In line with this recommendation, a com-
parison of MidU primary and some secondary outcome
results with the Cochrane Review of midwife-led versus
consultant-led care was conducted, [7] and shows some
differences but many similarities. Only those results
where the addition of the MidU data did not lead to
substantial increases in the I
2 statistic for heterogeneity
(greater than I
2 = 75%) have been presented.
The addition of the MidU findings strengthens the
findings of the review, increasing the statistical power of
the meta-analyses and changing some results from sta-
tistically significant to non-significant for the secondary
outcomes of ‘antenatal hospitalisation’ (RR 0.90 95% CI
0.81, 0.99 I
2 = 32% without MidU, to RR 0.96 95% CI
0.89, 1.03 I
2 = 49% with MidU); and ‘fetal/neonatal loss
before 24 weeks’ (RR 0.79 95% CI 0.65, 0.97 I
2 =0 %
without MidU, to RR 0.82, 95% CI 0.67, 1.00 I
2 =0 %
with MidU). The addition of MidU also changes the
results of the meta-analyses from non-significant to sig-
nificant in favour of MLU for the outcome ‘amniotomy’
(RR 0.88 95% CI 0.75, 1.04 I
2 =4 1 %w i t h o u tM i d U ;t o
RR 0.80 95% CI 0.66, 0.97 I
2 = 74% with MidU), and in
favour of CLU for the outcome ‘shorter mean length of
labour’ (mean difference 0.27 95% CI -0.18, 0.72 I
2 =
0% without MidU to mean difference 0.46 95% CI 0.22,
0.70 I
2 = 0% with MidU). As in MidU, four studies
included in the Cochrane Review [7] found significant
reduced rates of augmentation of labour in MLUs, but
the remaining six showed no difference. Overall, meta-
analyses do not show a significant difference in this out-
come, with or without the addition of MidU data [6]. In
the MidU study, induction of labour, PPH and low
Apgar scores were not different between the two
groups, in accord with the Cochrane Review findings.
The MidU study, in common with eight others in the
review, showed a reduction in instrumental birth in
MLUs, which was not statistically significant. The
increased power available in the Cochrane meta-analy-
sis, before and after addition of the MidU data, con-
tinues to show a significant decrease in instrumental
birth rates in favour of MLUs [7]. Similarly, the MidU
study, in common with five others in the Cochrane
Review, showed a non-significant reduction in episio-
tomies for MLU women. One other study in the review
showed no difference, but five showed a statistically sig-
nificant difference in favour of MLU care. The increased
power available in the Cochrane meta-analysis, before
and after addition of the MidU data, shows a significant
difference in episiotomy rate in favour of MLUs [7].
Consistent with MidU, the Cochrane Review finds no
significant difference in ‘fetal loss/neonatal death equal
to/after 24 weeks’ before and after the addition of MidU
data.
In summary, MidU adds to the totality of evidence
available by substantiating and adding to the results of
previous research. The similarity between MidU and
other international studies in the Cochrane Review
shows that our findings have good generalisability.
Further research is necessary into ways of decreasing
non-essential interventions for healthy women in normal
labour, to increase the normal birth rate for healthy
women at low risk to complications.
Conclusions
This study supports the recommendation of the
Cochrane Review [7] that midwife-led care should be
offered to most women. The implications of this for
maternity care are profound, particularly in Ireland
where at least 40% of women are eligible, and suitable,
for midwife-led care (using strict criteria), which has
b e e ns h o w nt ob ea ss a f ea sc o n s u l t a n t - l e dc a r eb u t
associated with less intervention when provided in an
‘alongside’ MLU. Therefore, it is reasonable to suggest
that midwife-led care should be the norm for low-risk
women. Consideration should be given to the establish-
m e n to fM L U sw h e r et h e ya r en o tt h en o r m ,u s i n gt h e
model of midwife-led care practised in this study, with
similar resources.
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